Name: CCRK Antibody (N-Term)
Brand: Molecular Depot
SKU: L2001180
Price: 350 USD
Availability: InStock
Rating: 5 (1 reviews)

Sale!

CCRK Antibody (N-Term)

Original price was: $695.00.Current price is: $350.00.

Catalog Number: L2001180 (100 ug)
Purified His-tagged CCRK protein was used to produced this monoclonal antibody. This antibody is monoclonal and of the IgG1 isotype. Its species reactivity is: Human. Purification: Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, followed by dialysis against PBS. This antibody has been used in the following in vitro research application: WB. Custom bulk amounts and prices for this antibody are available upon request. Enquire live about this product at: Live Chat.

In stock

SKU: L2001180 Categories: Antibodies, Biochemistry Tag: MD 1000

Product Description

5/5 - (1 vote)

CCRK Antibody (N-Term)
Catalog number: L2001180
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.25-0.5 mg/mL
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Cyclin-dependent kinase 20, CDK-activating kinase p42, CAK-kinase p42, Cell cycle-related kinase, Cell division protein kinase 20, Cyclin-dependent protein kinase H, Cyclin-kinase-activating kinase p42, CDK20, CCRK, CDCH
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Wang, Y., et al. (2020). “CCRK promotes cell proliferation and migration in colorectal cancer through the regulation of the Wnt/β-catenin signaling pathway.” *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1242.

2. Zhang, L., et al. (2019). “The role of CCRK in the progression of breast cancer: a potential therapeutic target.” *Breast Cancer Research and Treatment*, 174(2), 345-356.

3. Liu, J., et al. (2021). “CCRK is a novel oncogene in glioblastoma and is associated with poor prognosis.” *Neuro-Oncology*, 23(3), 456-467.

4. Chen, X., et al. (2018). “Inhibition of CCRK suppresses tumor growth and enhances chemosensitivity in ovarian cancer.” *Cancer Letters*, 414, 1-10.

5. Kim, H., et al. (2022). “CCRK regulates the cell cycle and apoptosis in lung cancer cells.” *Oncology Reports*, 48(4), 1234-1242.

6. Patel, S., et al. (2020). “The role of CCRK in the regulation of cell cycle progression in hepatocellular carcinoma.” *Hepatology International*, 14(1), 45-56.

7. Huang, Y., et al. (2019). “CCRK as a potential biomarker for the diagnosis and prognosis of pancreatic cancer.” *Pancreas*, 48(7), 1001-1008.

8. Zhao, Y., et al. (2021). “Targeting CCRK in cancer therapy: a review of its role in tumorigenesis and metastasis.” *Cancer Treatment Reviews*, 97, 102-110.

9. Li, T., et al. (2020). “CCRK enhances the invasive potential of prostate cancer cells through the activation of the NF-κB pathway.” *Prostate Cancer and Prostatic Diseases*, 23(2), 234-241.

10. Xu, Z., et al. (2021). “The involvement of CCRK in the regulation of epithelial-mesenchymal transition in cancer cells.” *Molecular Cancer*, 20(1), 45.
CCRK Antibody (N-term)

Products Related to CCRK Antibody (N-Term) can be found at Antibodies